IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
暂无分享，去创建一个
D. Booth | A. Mangia | G. Ahlenstiel | J. Nattermann | U. Spengler | W. Irving | M. Romero-Gómez | J. George | E. Bugianesi | A. Zaitoun | M. Douglas | M. Eslam | W. Cheng | D. Sheridan | V. Attino | D. Mcleod | L. Mollison | R. Leung | Diane Goeltz | M. Romero‐Gomez | D. McLeod